Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Guidelines for the management of hereditary ATTR amyloidosis 2026.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 09, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.
Journal: Journal of the peripheral nervous system : JPNS
Published: June 05, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: June 03, 2026
Disease burden of ATTR amyloidosis based on the SF-36® health survey.
Journal: Cardio-oncology (London, England)
Published: December 15, 2025
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.
Journal: Journal of cardiac failure
Published: November 26, 2025
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.
Journal: JAMA cardiology
Published: November 08, 2025
Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: October 28, 2025
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.
Journal: Muscle & nerve
Published: August 07, 2025
Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis.
Journal: Circulation. Heart failure
Published: March 31, 2025
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B.
Journal: Journal of the American College of Cardiology
Published: February 08, 2025
Correction: Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform.
Journal: Journal of neurology
Published: February 03, 2025
Last Updated: 09/26/2026